Estimation of efficiency of combined therapy of vitamin d deficiency conditions by combining cholecalcipherol drugs and correction of nutritive status

  • Babienko Vladimir Vladimirivich Odessa State Medical University https://orcid.org/0000-0002-4597-9908 Email: v_babienkov@ukr.net
  • Shanyhin Anton Viktorovich Odessa State Medical University https://orcid.org/0000-0003-2644-4542 Email: anton_shanygin@onmedu.edu.ua
  • Babich Maiia Sergeevna Odessa State Medical University Email: maiya_23@rambler.ru
Keywords: cholecalciferol, vitamin D, vitamin D deficiency and deficiency, correction of nutritional status, drug therapy

Abstract

 

Abstract

Thanks to the development of modern medical science, every year more and more new functions and mechanisms of action of vitamins are discovered, their role in the development and prevention of many diseases is being reviewed. Today, vitamin D deficiency and deficiency is becoming a pandemic. Therefore, the urgent issue is the study of the mechanisms of development of vitamin D deficient conditions, the role of vitamin D in the development of many diseases, improving the methods of diagnosis and prevention, developing clinical recommendations. Based on the discovery and identification of the role of specific vitamin D receptors (VDR), the pleiotropic effects of vitamin D have been proven. The potential benefits of vitamin D in the fight against aging and the development of age-associated diseases are of great importance. This article provides a comparative assessment of the effectiveness of therapy for vitamin D deficiency conditions by correcting the nutritional status of patients with the inclusion of vitamin D-rich foods in the diet, taking into account the necessary therapeutic dose. Separately, an analysis of combination therapy, vitamin D deficient conditions, involving a combination of cholecalciferol and alimentary correction was performed. To diagnose vitamin D deficiency and deficiency, methods such as questionnaires and laboratory diagnostics (ELISA determination of the level of 25-hydroxyvitamin D-25 (OH) D in blood serum) were used. Based on the initial results obtained, therapy was assigned individually for each patient. It was found that the combined use of nutritional correction and drug therapy is more effective than dietary therapy without the additional use of cholecalciferol.

Downloads

Download data is not yet available.

Author Biographies

Babienko Vladimir Vladimirivich, Odessa State Medical University

MD, PhD, Professor, Head of General Hygiene and Ecology Department

Shanyhin Anton Viktorovich, Odessa State Medical University

Assistant of General Hygiene and Ecology Department

Babich Maiia Sergeevna, Odessa State Medical University

medical student

References

Поворознюк В.В., Плудовски П., Балацкая Н.И., Муц В.Я. Дефицит и недостаточность витамина D: эпидемиология, диагностика, профилактика и лечение: Монография. 2015. Издательство: Заславский А.Ю. Донецк. 262 с.
2. McGrath J., Saari K., Hakko H., et al. Vitamin D supplementation during the first year of life and riskof schizophrenia: a Finnish birth cohort study // Schizophr Res. 2004. Vol. 67, P. 237-245.
3. Hayes C. E., Nashold F. E., Spach K. M., Pedersen L. B. The immunological functions of the VitaminD endocrine system // Cellular and Molecular Biology. 2003. Vol. 49(2). P. 277-300.
4. Asaka M., Iida H., Izumino K., Sasayama S. Depressed natural killer cell activity in uremia. Evidencefor immunosuppressive factor in uremic sera // Nephron. 1988. Vol. 49(4). P. 291-295.
5. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? // British Journal of Nutrition. 2003. Vol. 89(5). P. 552-572.
6. Beveridge L.A., Witham M.D. Vitamin D and the cardiovascular system. // Osteoporosis International. 2013. Vol. 24(8). Р. 2167-2180. (in English)
7. Ford J.A., MacLennan G.S., Avenell А. et al. Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. //American Jo of Clinical Nutrition. 2014. Vol. 100(3). Р. 746-755.
8. Müller K., Haahr P.M., Diamant M. et al. 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. // Cytokine. 1992. Vol. 4(6). Р. 506-512.
9. Johnson J.A., Grande J.P., Roche P.C., Kumar R. Immunohistochemical localization of the 1, 25(OH)2D3 receptor and calbindin D28K in human and rat pancreas //Am J Physiol. 1994. Vol. 261(3). Р. 356-360.
10. Gedik A., Akalin S. Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. // Diabetologia. 1986. Vol. 29(3). Р. 142-145.
11. Сердюк А.М., Гуліч М.П., Каплуненко В.Г., М.В. Косінов М.В. Нанотехнології мікронутрієнтів: проблеми, перспективи та шляхи ліквідації дефіциту макро- та мікроелементів. // Журнал Національної академії медичних наук України. 2010. Т. 16. № 1. С. 107-114.
12. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. // J Clin Endocrinol Metab. 2011. Vol. 96(7). P. 1911-30. doi: 10.1210/jc.2011-0385. Epub (in English)

REFERENCES
1. Povoroznyuk V.V., Pludovski P., Balatskaya N.I., Muts V.YA. (2015) Defitsit i nedostatochnost' vitamina D: epidemiologiya, diagnostika, profilaktika i lecheniye: Monografiya. Izdatel'stvo: Zaslavskiy A.YU. Donetsk. 262 s. (in Russian)
2. McGrath J., Saari K., Hakko H., et al. (2004). Vitamin D supplementation during the first year of life and riskof schizophrenia: a Finnish birth cohort study// Schizophr Vol. 67, pp. 237-245. (in English)
3. Hayes C. E., Nashold F. E., Spach K. M., Pedersen L. B. (2003) The immunological functions of the VitaminD endocrine system. Cellular and Molecular Biology. Vol.49(2), pp. 277-300. (in English)
4. Asaka M., Iida H., Izumino K., Sasayama S. (1988) Depressed natural killer cell activity in uremia. Evidencefor immunosuppressive factor in uremic sera. Nephron. Vol. 49(4), pp. 291-195. (in English)
5. Zittermann A. (2003) Vitamin D in preventive medicine: are we ignoring the evidence? British Journal of Nutrition. Vol. 89(5), pp. 552-572. (in English)
6. Beveridge L.A., Witham M.D. (2013) Vitamin D and the cardiovascular system. Osteoporosis International. Vol. 24(8), pp. 2167-2180. (in English)
7. Ford J.A., MacLennan G.S., Avenell А. et al. (2014) Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. American Jo of Clinical Nutrition. Vol. 100(3), pp. 746-755. (in English)
8. Müller K., Haahr P.M., Diamant M. et al. (1992) 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine. Vol. 4(6), pp. 506-512. (in English)
9. Johnson J.A., Grande J.P., Roche P.C., Kumar R. (1994) Immunohistochemical localization of the 1, 25(OH)2D3 receptor and calbindin D28K in human and rat pancreas. Am J Physiol. Vol. 261(3), pp. 356-360 (in English)
10. Gedik A., Akalin S. (1986) Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia. Vol. 29(3), pp. 142-145. (in English)
11. Serdyuk A.M., Hulich M.P., Kaplunenko V.H., M.V. Kosinov M.V. (2010). Nanotekhnolohiyi mikronutriyentiv: problemy, perspektyvy ta shlyakhy likvidatsiyi defitsytu makro- ta mikroelementiv. Zhurnal Natsionalʹnoyi akademiyi medychnykh nauk Ukrayiny. – Vol.. 16, N 1. pp. 107-114. (in Ukrain)
12. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. (2011) Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011. Vol 96(7), pp. 1911-1930. doi: 10.1210/jc.2011-0385. Epub (in English)
Published
2020-06-29
How to Cite
Babienko V. V., Shanyhin A. V., Babich M. S. Estimation of efficiency of combined therapy of vitamin d deficiency conditions by combining cholecalcipherol drugs and correction of nutritive status // Health, physical culture and sports, 2020. Vol. 19, № 3. P. 17-30. URL: http://hpcas.ru/article/view/8128.
Section
Medical and biological issues of human health
Bookmark and Share